Fadi Haddad, MD
Surgery · Bloomington, INNPI 1932194511
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Myriad Genetic Laboratories, Inc. accounts for 62.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $6,712 and has fallen 96.0% since, to $272 in 2025.
Across 78 payments — averaging $132.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$6K
- Elucent Medical$1K
- Medtronic$1K
- TELA Bio, Inc.$246
- Daiichi Sankyo Inc.$166
- Regeneron Healthcare Solutions, Inc.$152
- plus $816 from 17 others
What the payments were for
- Speaking & faculty fees$5,95058%
- Travel & lodging$2,00719%
- Food & beverage$2,35823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 16 | $6,453 |
| Elucent Medical | 4 | $1,359 |
| Medtronic(2 entities) | 10 | $1,123 |
| TELA Bio, Inc. | 7 | $246 |
| Daiichi Sankyo Inc. | 5 | $166 |
| Regeneron Healthcare Solutions, Inc. | 3 | $152 |
| Novartis | 5 | $149 |
| Davol Inc. | 1 | $142 |
| Pacira Pharmaceuticals Incorporated | 8 | $135 |
| Integra Lifesciences Corporation | 4 | $127 |
| Sirius Medical Systems | 2 | $61 |
| Shionogi Inc | 1 | $32 |
| AbbVie(2 entities) | 2 | $26 |
| TEI Biosciences Inc | 1 | $23 |
| Smith+Nephew | 1 | $19 |
| Stryker | 1 | $16 |
| KCI USA, Inc. | 1 | $13 |
| Merit Medical Systems Inc | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Mallinckrodt Hospital Products Inc. | 1 | $12 |
| Angiodynamics, Inc. | 1 | $12 |
| THD America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$5,217
- PreciseTumor$850
- PIVOX Oblique Lateral Spinal System$849
- Phasix Mesh$142
- LIBTAYO$122
- Enhertu$109
How this compares
$10,315 in reported general payments places this provider in the 80th percentile of 524 surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 147 | $716 |
| Cephalexin | 22 | $121 |
Paid to pharmacies, not to this prescriber.
Other surgery in Bloomington
- Jason KennardBloomington$19K
- Paul SzotekIndianapolis$2.4M
- Carlos Gonzalez RendonMunster$275K
- Anthony ZappiaCarmel$105K
- Jeremy Luedtkela Porte$102K
- Patricia ClarkFort Wayne$82K
- Erica GiblinCarmel$70K
- Paul BowldsGreenwood$69K
- Michael MillerIndianapolis$53K
- M ShabeebMunster$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.